Last checked at 3 Jan 2024 17:10
Miners, personal goods stocks drag FTSE 100 to two-week low
Burberry slips on rating downgrade
*Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Glaxosmithkline Share News (GSK)
GSK Share
Price
GSK Share
News
GSK Share
Chat
GSK Share
Trades8,491
GSK
Live RNS
GSK Share
Charts
GSK Level 2
Console
GSK Live
Share Price
GSK Broker
Ratings
GSK Directors
Deals
GSK Financial
Diary
GSK
Fundamentals
GSK Short
Positions
GSK
Media
Glaxosmithkline Information
Share Price Information for Glaxosmithkline (GSK)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
1,670.00
Bid:
1,670.50
Ask:
1,671.00
Change:
17.00 (1.03%)
Spread:
0.50 (0.03%)
Open:
1,650.00
High:
1,677.00
Low:
1,646.00
Prev. Close:
1,653.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.Unilever close to buying GSK's Horlicks business - report
Wed, 28th Nov 2018 08:35
(Sharecast News) - Unilever is in pole position to guzzle up GlaxoSmithKline's Indian Horlicks business and associated nutrition brands for around $4bn, according to reports.Glaxo has granted its fellow FTSE 100 company exclusivity on talks, the Financial Times reported, as part of the drug giant's strategy to focus on its core business.The deal is expected to include the Horlicks malted drink brand as part of wider nutrition business listed in India and Bangladesh.Nestlé and Coca Cola were said to have been beaten off in the auction process.GSK owns a 72.5% stake in the Bombay Stock Exchange-listed business, which has a market cap of $4.2bn, plus a smaller Bangladesh-listed business. GSK, which is looking to double down on pharmaceuticals and healthcare businesses after buying out Novartis of their consumer healthcare joint venture earlier this year, made revenues of more than £0.5bn from nutrition products last year.Likewise, Anglo-Dutch consumer goods colossus Unilever has refined its focus following the sale of its spreads business a year ago for €6.825bn."The price for the Horlicks business would appear to be around $3.5bn to $4.5bn which given the growth potential would seem to be fairly good value," said analyst Michael Hewson at CMC Markets.
More News
3 Jan 2024 16:52
LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes
(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.
Read more3 Jan 2024 12:10
LONDON MARKET MIDDAY: Stocks down before Fed minutes and US PMI data
(Alliance News) - Stock prices in London were down at midday on Wednesday, in cautious trade ahead of key US data and central bank minutes in the afternoon.
Read more3 Jan 2024 11:07
Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'
(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.
Read more3 Jan 2024 09:23
LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'
(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:
Read more3 Jan 2024 08:58
LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses
(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.
Read more3 Jan 2024 07:54
LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data
(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.
Read more29 Dec 2023 13:01
LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023
(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.
Read more20 Dec 2023 13:29
GSK buys rights to Hansoh Pharma antibody-drug conjugate
(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.
Read more19 Dec 2023 15:36
German court quashes CureVac patent after challenge by BioNTech
CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue
*Read more18 Dec 2023 17:21
Energy stocks lift UK's FTSE 100, Vodafone shines
Vodafone jumps as Iliad offers to merge Italian units
*Read more18 Dec 2023 10:07
GSK's dostarlimab trial in endometrial cancer meets primary endpoint
(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.
Read more18 Dec 2023 07:55
LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000
(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.
Read more18 Dec 2023 07:18
GSK sees success in Jemperli endometrial cancer trial
(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.
Read more17 Dec 2023 15:16
PRESS: GSK looks for deals in China as rebuilds relationship
(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.
Read more